Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer

Gynecologic Oncology

Volumn 96, Issue 3, 2005, Pages 651-657

  Watari, Hidemichi ^a   Todo, Yukiharu ^a   Takeda, Mahito ^a   Ebina, Yasuhiko ^a   Yamamoto, Ritsu ^a   Sakuragi, Noriaki ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Endometrial carcinoma; Lymph vascular space invasion; Para aortic lymph node metastasis; Prognostic factor; Stage IIIc

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN;

CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONFERENCE PAPER; ENDOMETRIUM CARCINOMA; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PARAAORTIC LYMPH NODE; PATIENT SELECTION; PELVIS LYMPHADENECTOMY; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

EID: 13844266801     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.11.026     Document Type: Conference Paper

References (17)

1. A. Jemal, T. Murray, A. Samuels, A. Ghafoor, E. Ward, and M.J. Thun Cancer statistics, 2003 CA Cancer J. Clin. 53 2003 5 26
2. C.P. Morrow, B.N. Bundy, R.J. Kurman, W.T. Creasman, P. Heller, and H.D. Homesley Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a gynecologic oncology group study Gynecol. Oncol. 40 1991 55 65
3. K. Hirahatake, H. Hareyama, N. Sakuragi, M. Nishiya, S. Makinoda, and S. Fujimoto A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma J. Surg. Oncol. 65 1997 82 87
4. D. McMeekin, D. lashbrook, M. Gold, D.R. Scribner, S. Kamelle, and T.D. Tillmanns Nodal distribution and its significance in FIGO stage IIIc endometrial cancer Gynecol. Oncol. 82 2001 375 379
5. L.A. Katz, S.J. Andrews, and J. Fanning Survival after multimodality treatment for stage IIIC endometrial cancer Am. J. Obstet. Gynecol. 184 2001 1071 1073
6. G. Calais, P. Descamps, L. Vitu, G. Body, J. Lansac, and P. Bougnoux Is lymphadenectomy useful in the treatment of endometrial carcinoma? Gynecol. Oncol. 38 1990 71 75
7. W. Faught, G.V. Krepart, R. Lotocki, and M. Heywood Should selective para-aortic lymphadenectomy be part of surgical staging for endometrial cancer? Gynecol. Oncol. 55 1994 51 55
8. L.C. Kilgore, E.E. Partridge, R.D. Alvarez, J.M. Austin, H.M. Shingleton, and F. Noojin Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling Gynecol. Oncol. 56 1995 29 33
9. J. Fanning, and S. Firestein Prospective evaluation of the morbidity of complete lymphadenectomy in endometrial cancer Int. J. Gynecol. Cancer 8 1998 270 273
10. M. Nishiya, N. Sakuragi, H. Hareyama, Y. Ebina, M. Furuya, and M. Oikawa Cox multivariate regression models for estimating prognosis of patients with endometrioid adenocarcinoma of the uterine corpus who underwent through surgical staging Int. J. Cancer 79 1998 521 525
11. N. Sakuragi, H. Hareyama, Y. Todo, H. Yamada, R. Yamamoto, and T. Fujino Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma Acta Obstet. Gynecol. Scand. 79 2000 311 316
12. T. Onda, H. Yoshikawa, K. Mizutani, M. Mishima, H. Yokota, and H. Nagano Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy Br. J. Cancer 75 1997 1836 1841
13. M.E. Randall, G. Brunetto, and R.S. Mussetal Whole abdominal radiotherapy versus combination chemotherapy with doxorubicin and cisplatin in advanced endometrial carcinoma (phase III): gynecologic oncology group study no. 122 Proc. Am. Soc. Clin. Oncol. 21 2003 2
14. H.G. Ball, J.A. Blessing, and S.S. Lentz A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a gynecologic oncology group study Gynecol. Oncol. 62 1996 278 281
15. T. Ohkouchi, N. Sakuragi, H. Watari, E. Nomura, Y. Todo, and H. Yamada Prognostic significance of Bcl-2, p53 overexpression and lymph node metastasis in surgically staged endometrial carcinoma Am. J. Obstet. Gynecol. 187 2002 353 359
16. Y. Kanamori, J. Kigawa, H. Itamochi, H. Sultana, M. Suzuki, and M. Ohwada PTEN expression is associated with prognosis for patients with advanced endometrial carcinoma undergoing postoperative chemotherapy Int. J. Cancer 100 2002 686 689
17. Y. Yokoyama, D.S. Charnock-Jones, D. Licence, A. Yanaihara, J.M. Hastings, and C.M. Holland Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma Clin. Cancer Res. 9 2003 1361 1369